We provide you with 20 years of free, institutional-grade data for ABBV stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of ABBV. Explore the full financial landscape of ABBV stock.
| Reported Date | CIK | Ticker | Type | |
|---|---|---|---|---|
| 2025-08-04 | 1551152 | ABBV | 10-Q | Url |
| 2025-05-09 | 1551152 | ABBV | 10-Q | Url |
| 2025-02-14 | 1551152 | ABBV | 10-K | Url |
| 2024-11-04 | 1551152 | ABBV | 10-Q | Url |
| 2024-08-07 | 1551152 | ABBV | 10-Q | Url |
| 2024-05-03 | 1551152 | ABBV | 10-Q | Url |
| 2024-02-20 | 1551152 | ABBV | 10-K | Url |
| 2023-11-06 | 1551152 | ABBV | 10-Q | Url |
| 2023-08-07 | 1551152 | ABBV | 10-Q | Url |
| 2023-05-05 | 1551152 | ABBV | 10-Q | Url |
| 2023-02-17 | 1551152 | ABBV | 10-K | Url |
| 2022-11-04 | 1551152 | ABBV | 10-Q | Url |
| 2022-08-04 | 1551152 | ABBV | 10-Q | Url |
| 2022-05-06 | 1551152 | ABBV | 10-Q | Url |
| 2022-02-18 | 1551152 | ABBV | 10-K | Url |
| 2021-11-02 | 1551152 | ABBV | 10-Q | Url |
| 2021-08-02 | 1551152 | ABBV | 10-Q | Url |
| 2021-05-07 | 1551152 | ABBV | 10-Q | Url |
| 2021-02-19 | 1551152 | ABBV | 10-K | Url |
| 2020-11-04 | 1551152 | ABBV | 10-Q | Url |
| 2020-08-04 | 1551152 | ABBV | 10-Q | Url |
| 2020-05-08 | 1551152 | ABBV | 10-Q | Url |
| 2020-02-21 | 1551152 | ABBV | 10-K | Url |
| 2019-11-06 | 1551152 | ABBV | 10-Q | Url |
| 2019-08-05 | 1551152 | ABBV | 10-Q | Url |
| 2019-05-03 | 1551152 | ABBV | 10-Q | Url |
| 2019-02-27 | 1551152 | ABBV | 10-K | Url |
| 2018-11-07 | 1551152 | ABBV | 10-Q | Url |
| 2018-08-07 | 1551152 | ABBV | 10-Q | Url |
| 2018-05-04 | 1551152 | ABBV | 10-Q | Url |
| 2018-02-16 | 1551152 | ABBV | 10-K | Url |
| 2017-11-07 | 1551152 | ABBV | 10-Q | Url |
| 2017-08-07 | 1551152 | ABBV | 10-Q | Url |
| 2017-05-05 | 1551152 | ABBV | 10-Q | Url |
| 2017-02-17 | 1551152 | ABBV | 10-K | Url |
| 2016-11-07 | 1551152 | ABBV | 10-Q | Url |
| 2016-08-05 | 1551152 | ABBV | 10-Q | Url |
| 2016-05-06 | 1551152 | ABBV | 10-Q | Url |
| 2016-02-19 | 1551152 | ABBV | 10-K | Url |
| 2015-11-06 | 1551152 | ABBV | 10-Q | Url |
| 2015-08-07 | 1551152 | ABBV | 10-Q | Url |
| 2015-05-08 | 1551152 | ABBV | 10-Q | Url |
| 2015-02-20 | 1551152 | ABBV | 10-K | Url |
| 2014-11-07 | 1551152 | ABBV | 10-Q | Url |
| 2014-08-07 | 1551152 | ABBV | 10-Q | Url |
| 2014-05-09 | 1551152 | ABBV | 10-Q | Url |
| 2014-02-21 | 1551152 | ABBV | 10-K | Url |
| 2013-11-12 | 1551152 | ABBV | 10-Q | Url |
| 2013-08-09 | 1551152 | ABBV | 10-Q | Url |
| 2013-05-08 | 1551152 | ABBV | 10-Q | Url |
| 2013-03-15 | 1551152 | ABBV | 10-K | Url |
| 2012-12-10 | 1551152 | ABBV | S-1 | Url |
AbbVie Inc(NYSE:ABBV) 
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the...
Website: http://www.abbvie.com
Founded: 2013
Full Time Employees: 50,000 (Dec 2022)
CEO: Richard Gonzalez
Sector: Healthcare
Industry: Drug Manufacturers-General
The information provided in this report about ABBV stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.